Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jun Katori
TAS-102 Safety in Metastatic Colorectal Cancer: Results From the First Postmarketing Surveillance Study
Clinical Colorectal Cancer
Oncology
Gastroenterology
Related publications
A Systematic Review and Network Meta‐Analysis of Regorafenib and TAS‐102 in Refractory Metastatic Colorectal Cancer
Oncologist
Cancer Research
Medicine
Oncology
Phase I Study of TAS-102 and Irinotecan Combination Therapy in Japanese Patients With Advanced Colorectal Cancer
Investigational New Drugs
Oncology
Pharmacology
Feasibility of 7-T Fluorine Magnetic Resonance Spectroscopic Imaging (19F MRSI) for TAS-102 Metabolite Detection in the Liver of Patients With Metastatic Colorectal Cancer
European radiology experimental
Nuclear Medicine
Radiology
Imaging
PCN22 Safety Profile of Bevacizumab in Metastatic Colorectal Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan
Journal of Rheumatology
Rheumatology
Allergy
Immunology
A Trial Protocol of Biweekly TAS-102 and Bevacizumab as Third-Line Chemotherapy for Advanced/Recurrent Colorectal Cancer: A Phase II Multicenter Clinical Trial (The TAS-CC4 Study)
Journal of the Anus, Rectum and Colon
Cetuximab in First Line Treatment of Metastatic Colorectal Cancer
Farmeconomia. Health economics and therapeutic pathways
Discontinuation of First-Line Bevacizumab in Metastatic Colorectal Cancer: The BEAWARE Italian Observational Study
Tumori
Medicine
Cancer Research
Oncology
Bevacizumab in First-Line Treatment of Elderly Patients With Metastatic Colorectal Cancer: German Community-Based Observational Cohort Study Results
BMC Cancer
Cancer Research
Oncology
Genetics
